About Orifarm Group A/S
One of Europe's largest parallel importers of pharmaceuticals. Supplies generic and original medicines across all Nordic countries with expertise in EU regulatory pathways and cost-effective distribution.
Orifarm Group A/S operates across the broader pharmaceutical category. For a first conversation, be specific about product category, target channel (public/private, clinical/retail) and expected annual volume — Nordic distributors respond better to targeted, well-researched approaches than to generic distribution requests.
Nordic coverage
- Sweden — see all Sweden distributors
- Denmark — see all Denmark distributors
- Norway — see all Norway distributors
- Finland — see all Finland distributors
Orifarm Group A/S operates as a pan-Nordic pharmaceutical distributor, meaning one contract gives a foreign supplier access to Sweden, Denmark, Norway and Finland through a single commercial and regulatory counterparty. Pan-Nordic distributors are typically the fastest route to market for manufacturers who prioritise speed and simplicity over country-level pricing optimisation. Due diligence checklist: confirm physical presence in each country (warehouse, field sales, regulatory staff), verify tender-winning track record per country, and align on clinical / commercial support capability.
Ask about Orifarm Group A/S
Send an enquiry about this distributor to the NordicDistributors team. We review enquiries manually. This form does not send your message directly to the distributor.
Brief received
Your enquiry has been received by the NordicDistributors team for manual review. No automatic message has been sent to the distributor.
Explore current product opportunities
Browse products available for distribution or publish your own product listing.
Browse opportunities →Contact & details
The Nordic pharmaceutical context
Nordic pharmaceutical distribution is dominated by full-line wholesalers (Oriola, Tamro) plus a long tail of specialty distributors in oncology, rare disease, biologics and hospital-only products. Every distributor operates under a national wholesale licence and GDP certificate issued by Läkemedelsverket (SE), Lægemiddelstyrelsen (DK), Legemiddelverket (NO) or Fimea (FI). Reimbursement goes through TLV, Medicinrådet, Beslutningsforum and PPB respectively.
A clear commercial direction for your Nordic growth
Fractio offers bespoke advisory on market priorities, distribution strategy and commercial planning. Scope, deliverables, fees and timing are agreed in a separate proposal.
Consulting is optional and contracted separately from product advertising. Browsing opportunities, contacting advertisers and requesting a basic distributor listing remain free.
Discuss your commercial priorities →